🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic material and prohibited associated keywords and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Research also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of joining one group, a vendor posted WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Item Details and Costs

Inside these communities, messages show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may subject users to potentially serious health risks”.